GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination

Neuron

Volumn 17, Issue 4, 1996, Pages 607-615

  Liedtke, Wolfgang ^a   Edelmann, Winfried ^a   Bieri, Phyllis L ^a   Chiu, Fung Chow ^a   Cowan, Nicholas J ^b   Kucherlapati, Raju ^a   Raine, Cedric S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; GENE MUTATION; MOUSE; MYELINATION; NERVE FIBER; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE; PRIORITY JOURNAL; WHITE MATTER;

EID: 0030273614     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80194-4     Document Type: Article

References (47)

1. Abney, E.R., Williams, B.P., and Raff, M.C. (1983). Tracing the development of oligodendrocytes from precursor cells using monoclonal antibodies, fluorescence-activated cell sorting and cell culture. Dev. Biol. 100, 166-171.
2. Balcarek, J.M., and Cowan, N. (1985). Structure of the mouse glial fibrillary protein gene: implications for the evolution of the intermediate filament multigene family. Nucl. Acids Res. 13, 5527-5543.
3. Baron-van Evercooren, A., Jensen, N.A., Wyss, M.T., Cuzin, F., Rassoulzadegan, M., Brucher, J.M., and Baron, H. (1992). Transgenic mice expressing polyoma virus large T antigen in astrocytes develop severe dysmyelination of the central nervous system. Lab. Invest. 66, 39-53.
4. Bartlett, W.P., Knapp, P.E., and Skoff, R.P. (1988). Glial conditioned medium enables jimpy oligodendrocytes to express properties of normal oligodendrocytes: production of myelin antigens and membranes. Glia 1, 253-259.
5. Blakemore, W.F., and Franklin, J.M. (1991). Transplantation of glial cells into the central nervous system. Trends Neurosci. 14, 323-327.
6. Boegler, O., Wren, D., Barnett, S.C., Land, H., and Noble, M. (1990). Cooperation betwen two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocytes-type-2 astrocyte (o-2A) progenitor cells. Proc. Natl. Acad. Sci. USA 87, 6368-6372.
7. Bunge, R.P., and Glass, P.M. (1965). Some observations on myelin-glial relationships and on the etiology of the cerebrospinal fluid exchange lesion. Ann. NY Acad. Sci. 122, 15-28.
8. Bunge, M., Bunge, R.P., and Ris, H. (1961). Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord. J. Biophys. Biochem. Cytol. 10, 67-94.
9. Chiu, F.-C., Barnes, E.A., Das, K., Haley, J., Socolow, P., Macaluso, F.P., and Fant, J. (1989). Characterization of a novel 66 kD subunit of mammalian neuronal intermediate filaments. Neuron 2, 1435-1445.
10. Eng, L.F., and Ghirnikar, R.S. (1994). Glial fibrillary acidic protein and astrogliosis. Brain Pathol. 4, 229-237.
11. Eng, L.F., Vanderhaeghen, J.J., Bignami, A., and Gerstl, B. (1971). An acidic protein isolated from fibrous astrocytes. Brain Res. 28, 351-354.
12. Feng, L., Hatten, M.E., and Heintz, N. (1994). Brain-lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS. Neuron 12, 895-908.
13. Fuchs, E., and Weber, K. (1994). Intermediate filaments: structure, dynamics, function and disease. Annu. Rev. Biochem. 63, 345-382.
14. Gallo, V., and Armstrong, R.C. (1995). Developmental and growth factor-induced regulation of nestin in oligodendrocyte lineage cells. J. Neurosci. 15, 394-406.
15. Gard, A.L., Burrell, M.R., Pfeiffer, S.E., Rudge, U.S., and Williams, W.C., II. (1995). Astroglial control of oligodendrocyte survival mediated by platelet derived growth factor and leukemia-inhibitory factor-like protein. Development 121, 2187-2197.
16. Goldmuntz, E.A., Brosnan, C.F., and Norton, W.T. (1986). Prazosin treatment suppresses increased vascular permeability in both acute and passively transferred experimental autoimmune encephalomyelitis in the Lewis rat. J. Immunol. 137, 3444-3450.
17. Gomi, H., Yokoyama, T., Fujimoto, K., Ikeda, T., Katoh, A., Itoh, T., and Itohara, S. (1995). Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 14, 29-41.
18. Goss, J.R., Fich, C.E., and Morgan, D.G. (1991). Age related changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol. Aging 12, 165-170.
19. Handyside, A.H., O'Neill, G.T., Jones, M., and Hooper, M.L. (1989). Use of BRL-conditioned medium in combination with feeder layers to isolate a diploid embryonal stem cell line. Roux's Arch. Dev. Biol. 198, 48-55.
20. Janzer, R.C., and Raff, M.C. (1987). Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325, 253-256.
21. Kandel, E.R. (1991). Nerve cells and behavior: glial cells. In Principles of Neural Science. E.R. Kandel, J.H. Schwartz, and T.M. Jessell, eds. (New York: Elsevier), pp. 22-24.
22. Landry, C.F., Ivy, G.O., and Brown, I.R. (1990). Developmental expression of glial fibrillary acidic protein mRNA in the rat brain analyzed by in-situ hybridization. J. Neurosci. Res. 25, 194-203.
23. Lazarides, E. (1980). Intermediate filaments as mechanical integrators of cellular space. Nature 283, 249-256.
24. McCall, M.A., Gregg, R.G., Behringer, R.R., Brenner, M., Delaney, C.L., Galbreath, E.J., Zhang, C.L., Pearce, R.A., Chiu, S.Y., and Messing, A. (1996). Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc. Natl. Acad. Sci. USA 93, 6361-6366.
25. McKinnon, R.D., Matsui, T., Dubois-Dalcq, M., and Aaronson, S.A. (1990). FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5, 603-614.
26. Michaelson M.D., Bieri, P.L., Mehler, M.F., Xu, H., Arezzo, J.C., Pollard, J.W., and Kessler, J.A. (1996). CSF-1 deficiency in mice results in abnormal brain development. Development, in press.
27. Moore, G.R.W., and Raine, C.S. (1988). Immunogold localization and analysis of IgG during immune-mediated demyelination. Lab. Invest. 59, 641-648.
28. Moore, G.R.W., McCarron, R.M., McFarlin, D.E., and Raine, C.S. (1987). Chronic relapsing necrotizing encephalomyelitis produced by myelin basic protein in mice. Lab. Invest. 57, 157-167.
29. Nicholson, C., and Freeman, J.A. (1975). Theory of current source -density analysis and determination of conductivity tensor for anuran cerebellum. J. Neurophysiol. 38, 356-368.
30. Noble, M., Murray, K., Stroobant, P., Water-field, M.D., and Riddle, P. (1988). Platelet derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/ type-2 astrocyte progenitor cell. Nature 333, 560-562.
31. Pekny, M., Leveen, P., Pekna, M., Eliasson, C., Berthold, C.-H., Westermark, B., and Betsholtz, C. (1995). Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J. 14, 1590-1598.
32. Privat, A., Giminez-Ribotta, M., and Ridet, J.-L. (1995). Morphology of astrocytes. In Neuroglia, H. Kettenmann and B.R. Ransom, eds. (New York: Oxford University press), pp. 3-22.
33. Raff, M.C., Lillien, L.E., Richardson, W.D., Burne, J.F., and Noble, M.D. (1988). Platelet derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333, 562-565.
34. Raine, C.S. (1984). On the association between perinodal astrocytic processes and the node of Ranvier in the central nervous system. J. Neurocytol. 13, 21-27.
35. Raine, C.S. (1991). Oligodendrocytes and central nervous system myelin. In Textbook of Neuropathology, second edition, R.L. Davis and D.M. Robertson, eds. (Baltimore, Maryland: Williams and Wilkins), pp. 115-141.
36. Rakic, P. (1981). Neuronal-glial interactions during brain development. Trends Neurosci. 4, 184-187.
37. Richardson, W.D., Pringle, N., Mosley, M.J., Westermark, B., and Dubois-Dalcq, M. (1988). A role for platelet derived growth factor in normal gliogenesis in the central nervous system. Cell 53, 309-319.
38. Shibuki, K., Gomi, H., Chen, L., Bao, S., Kim, J.J., Wakatsuki, H., Fujisaki, T., Fujimoto, K., Katoh, A., Ikeda, T., Chen, C., Thompson, R.F., and Itohara, S. (1996). Deficient cerebellar long term depression, impaired eyeblink conditioning, and normal motor coordination in glial fibrillary acidic protein mutant mice. Neuron 16, 587-599.
39. Sirotkin, A.M., Edelmann, W., Cheng, G., Klein-Szanto, A., Kucherlapati, R., and Skoultchi, A.I. (1995). Mice develop normally without the H1(0) linker histone. Proc. Natl. Acad. Sci. USA 92, 6434-6438.
40. Skoff, R. (1976). Myelin deficit in the jimpy mouse may be due to cellular abnormalities in astroglia. Nature 264, 560-562.
41. Vaughn, J.E., and Peters, A. (1967). Electron microscopy of the early postnatal development of fibrous astrocytes. Am. J. Anat. 121, 131-152.
42. Virchow, R. (1846). Ueber das granulierte Aussehen der Wandungen der Gehirnventrikel. Allg. Z. Psychiatr. 3, 242-255.
43. Weinstein, D.E., Shelanski, M.L., and Liem, R.K.H. (1991). Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J. Cell Biol. 112, 1205-1213.
44. Wren, D., and Noble, M. (1989). Oligodendrocytes and oligodendrocyte-type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc. Natl. Acad. Sci. USA 86, 9025-9029.
45. Wu, E., and Raine, C.S. (1992). Multiple sclerosis: interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, nondemyelinating conditions. Lab. Invest. 76, 88-99.
46. Yu, A.C.H., Lee, Y.-L., and Eng, L.F. (1991). Inhibition of GFAP synthesis by antisense RNA in astrocytes. J. Neurosci. Res. 30, 72-79.
47. Yu, A.C.H., Lee, Y.-L., and Eng, L.F. (1993). Astrogliosis in culture. I. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis. J. Neurosci. Res. 34, 295-303.